Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ripasudil (Ripasudil hydrochloride dihydrate) 是一种 ROCK 特异性抑制剂,能够抑制 ROCK1和 ROCK2的活性,IC50值分别为 51 和 19 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 547 | 现货 | ||
2 mg | ¥ 783 | 现货 | ||
5 mg | ¥ 1,330 | 现货 | ||
10 mg | ¥ 2,160 | 现货 | ||
25 mg | ¥ 3,690 | 现货 | ||
50 mg | ¥ 5,330 | 现货 | ||
100 mg | ¥ 7,520 | 现货 | ||
500 mg | ¥ 14,800 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,150 | 现货 |
产品描述 | Ripasudil (Ripasudil hydrochloride dihydrate) (K-115) hydrochloride dihydrate is a specific ROCK inhibitor (IC50s: 51/19 nM for ROCK1/ROCK2). |
靶点活性 | ROCK1:51 nM, ROCK2:19 nM, CaMK IIa:370 nM, PKC:27 μM, PKACa:2.1 μM |
体外活性 | Ripasudil 对CaMKIIα、PKACα和PKC的抑制活性较弱(IC50分别为370 nM、2.1 μM和27 μM)[1]。在培养的小梁细胞(TM细胞)中,Ripasudil(1、10 μM)可引起细胞骨架的变化,包括细胞收缩和圆化以及肌动蛋白束的减少。此外,Ripasudil(5 μM)显著降低Schlemm's管内皮(SCE)细胞单层的跨内皮电阻(TEER),并增加FITC-右旋糖酐的通透性[2]。 |
体内活性 | Ripasudil在浓度依赖的方式下降低猴眼内0.1%至0.4%之间以及兔眼内0.0625%至0.5%之间的眼内压[1]。Ripasudil(1 mg/kg,p.o. 每日一次)在神经压迫(NC)后对视网膜神经节细胞(RGCs)表现出神经保护效果。此外,Ripasudil还能抑制小鼠轴突损伤引起的氧化应激。Ripasudil在NC损伤后抑制RGCs中依时间产生的ROS[3]。 |
激酶实验 | ROCK 1 (0.75 ng/mL) and ROCK 2 (0.5 ng/mL) are incubated with various concentrations of Ripasudil, Y-27632, or HA-1077 at 25°C for 90 min in 50 mM Tris-HCl buffer (pH 7.5) containing 100 mM KCl, 10 mM MgCl2, 0.1 mM EGTA, 30 mM Long S6 Kinase Substrate peptide, and 1 mM ATP in a total volume of 40 mL. PKACa, PKC, and CaMKIIa are also incubated with various concentrations of Ripasudil, Y-27632, or HA-1077. PKACa (0.0625 ng/mL) is incubated at 25°C for 30 min in 40 mM Tris-HCl buffer (pH 7.5) containing 20 mM MgCl2, 1 mg/ mL BSA, 5 mM Kemptide peptide substrate, and 1 mM ATP in a total volume of 40 mL. PKC (0.025 ng/mL) is incubated at 25°C for 80 min in 20 mM Tris-HCl buffer (pH 7.5) containing 20 mM MgCl2, 0.4 mM CaCl2, 0.1 mg/mL BSA, 0.25 mM EGTA, 25 ng/mL phosphatidylserine, 2.5 ng/mL diacylglycerol, 0.0075% Triton-X-100, 25 mM DTT, 10 mM Neurogranin (28-43) peptide substrate, and 1 mM ATP in a total volume of 40 mL. CaMKIIa (0.025 ng/mL) is incubated at 25°C for 90 min in 50 mM Tris-HCl buffer (pH 7.5) containing 10 mM MgCl2, 2 mM CaCl2, 0.04 mg/mL BSA, 16 mg/mL purified calmodulin from bovine testis, 500 mM DTT, 50 mM Autocamitide 2, and 1 mM ATP in a total volume of 40 mL. After incubation, 40 mL of KinaseGlo Luminescent Kinase Assay solution is added, and allowed to remain at 25°C for 10 min, and Relative Light Units (RLU) are measured using a luminometer. The RLU without test compound is set as 100% (Control value), and that without enzyme and compound is set as 0% (Normal value). The reaction rate (% of control) is then calculated from the RLU with addition of each concentration of test compounds, and the 50% inhibitory concentrations (IC50) are determined by logistic regression analysis using SAS [1]. |
细胞实验 | Trabecular meshwork (TM) cells are plated on 6 well plates at a density of 1?×?10^4 cells per well in DMEM containing 10% FBS. Following overnight culture, when cells have reached semiconfluence, 1 or 10?μM of Ripasudil, 10?μM of Y-27632, or 10?μM of fasudil are added to culture wells. PBS is used as a control vehicle. After 60?min, drug solutions are removed and replaced with DMEM containing 10% FBS. Cells are observed by phase-contrast microscopy and photographed 60?min after drug application and 2?h after drug removal. For immunohistochemistry, TM cells are plated on gelatin-coated 8 well chamber slides at a density of 1?×?10^4 cells per well in DMEM containing 10% FBS. After overnight culture, when cells reach semiconfluence, cells are incubated in Ripasudil at 1 or 10?μM, Y-27632 at 10?μM, or fasudil at 10?μM for 60?min. PBS is used as a control vehicle. Drug solutions are removed and replaced with DMEM containing 10% FBS after 2?h. Cells are fixed with 4% paraformaldehyde in PBS for 15?min then washed with cytoskeletal buffer (10?mM MES, 150?mM NaCl, 5?mM EGTA, 5?mM MgCl2, 5?mM glucose, pH 6.1) and serum buffer (10% FBS in PBS). Cells are permeabilized with 0.5% Triton X-100 in PBS for 12?min at room temperature and blocked with serum buffer for at least 2?h at 4°C. Filamentous actin (F-actin) is labeled with 0.05?mg/mL Phalloidin-TRITC for 1?h at room temperature. After washing with PBS, cells are mounted with a commercial mounting medium containing DAPI and observed using a fluorescence microscope. The exposure to take images for F-actin and DAPI are 0.1 and 0.05?sec, respectively [2]. |
动物实验 | In the rabbit experiments, 50 mL of vehicle or Ripasudil at concentrations of 0.0625%, 0.125%, 0.25, or 0.5% is instilled into one eye. Intraocular pressure (IOP) is measured in both eyes before and 0.5, 1, 2, 3, 4, and 5 h after instillation. The contralateral eye is not treated. Animals are administered all concentrations of Ripasudil assigned using the Latin square method with intervals of at least 2 d. In the monkey experiments, 20 mL of Ripasudil at concentrations of 0.1%, 0.2%, or 0.4%, and latanoprost at a concentration of 0.005% are instilled into one eye. IOP is measured in both eyes before and 1, 2, 4, 6, and 8 h after instillation. The contralateral eye is not treated. Animals are arranged to receive all formulations with intervals of at least 1 week using the Latin square method. The IOPs are compared with the results for the instillation side at pre-dose and at each time point after the instillation of Ripasudil and are compared with both eyes at each time point. |
别名 | K-115, 瑞舒地尔盐酸二水合物, Ripasudil hydrochloride dihydrate |
分子量 | 395.88 |
分子式 | C15H23ClFN3O4S |
CAS No. | 887375-67-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 45 mg/mL (113.67 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O | 1 mM | 2.526 mL | 12.6301 mL | 25.2602 mL | 63.1504 mL |
5 mM | 0.5052 mL | 2.526 mL | 5.052 mL | 12.6301 mL | |
10 mM | 0.2526 mL | 1.263 mL | 2.526 mL | 6.315 mL | |
20 mM | 0.1263 mL | 0.6315 mL | 1.263 mL | 3.1575 mL | |
50 mM | 0.0505 mL | 0.2526 mL | 0.5052 mL | 1.263 mL | |
100 mM | 0.0253 mL | 0.1263 mL | 0.2526 mL | 0.6315 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Ripasudil 887375-67-9 Cell Cycle/Checkpoint Cytoskeletal Signaling Stem Cells ROCK inhibit K-115 K115 Ripasudil Hydrochloride Rho-kinase Rho-associated kinase ROK 瑞舒地尔盐酸二水合物 Ripasudil hydrochloride Dihydrate Ripasudil hydrochloride dihydrate Inhibitor K 115 Rho-associated protein kinase inhibitor